Published in
American Chemical Society, Journal of Medicinal Chemistry, 10(64), p. 6814-6826, 2021
DOI: 10.1021/acs.jmedchem.1c00067
Links
Tools
Fragment-Based Design of a Potent MAT2a Inhibitor and in Vivo Evaluation in an MTAP Null Xenograft Model
Journal article published in 2021 by
Claudia De Fusco 
,
Marianne Schimpl ,
Ulf Börjesson,
Tony Cheung,
Iain Collie,
Laura Evans,
Priyanka Narasimhan,
Christopher Stubbs,
Mercedes Vazquez-Chantada,
David J. Wagner ,
Michael Grondine,
Matthew G. Sanders,
Sharon Tentarelli,
Elizabeth Underwood,
Argyrides Argyrou
and other authors.
,
Marianne Schimpl ,
Ulf Börjesson,
Tony Cheung,
Iain Collie,
Laura Evans,
Priyanka Narasimhan,
Christopher Stubbs,
Mercedes Vazquez-Chantada,
David J. Wagner ,
Michael Grondine,
Matthew G. Sanders,
Sharon Tentarelli,
Elizabeth Underwood,
Argyrides Argyrou
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 